Age, Gender and length of illness’s relation with Hepatic Dysfunction in individuals having Malaria: A cross-sectional study: Hepatic Dysfunction in individuals having Malaria

Saima  Rafique; Tazeem  Hussain; Faima  `Rani Memon; Atif  Iqbal; Shafaq  Nazia Shaikh; Narindar  Kumar

doi:10.54393/pjhs.v3i04.89

Authors

Saima Rafique Bhitai Dental and Medical College Mirpurkhas Pakistan
Tazeem Hussain Department of Family Medicine Academy & Family Medicine Department, Kingdom of Saudi Arabia
Faima `Rani Memon Department of Physiology, BMC/Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Atif Iqbal Department of Family Medicine, Ministry of Health United Arab Emirates, UAE
Shafaq Nazia Shaikh Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Narindar Kumar Department of Medicine, Bhitai Dental and Medical College, Mirpur khas, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v3i04.89

Keywords:

Malaria, hepatic dysfunction, length of illness, age

Abstract

With almost 200 million medical cases occurring each year, malaria is the most common vector-borne disease worldwide. Objective: To ascertain the relationship of hepatic dysfunction with age, gender, and length of illness in individuals with malaria. Methods: Data were gathered using a non-probability consecutive sampling method. A total of 270 patients are selected for a sample using the Open Epi program, ranging in age from 25 to 65 and of either gender. Patients who tested positive for malarial parasites and had fever >104°F for longer than 4 days accompanied with chills, and rigors were selected. Patients with undiagnosed hepatomegaly and hepatic cirrhosis were excluded. Samples of blood were gathered and delivered to the pathology lab for biochemical evaluation. SPSS version 16.0 was used for data entry and analysis. For the numerical variables (such as age of the patients and disease duration), means and standard deviations were computed. The subjective variables (gender, age groups, length divisions, and hepatic dysfunction) were evaluated as percentages and frequencies. Results: A total of 270 individuals with confirmed cases of malaria were examined, having a mean age of 39.97 + 8.91 years. There were 70 (27.5%) women and 185 (72.5%) men. A total of 100 (37.3%) individuals with malaria had hepatic impairment. The only factor that significantly correlated (p0.03) to hepatic dysfunction was the length of the illness, whereas gender and various age categories did not. Conclusions: Only the length of the illness revealed a strong relationship between malaria and hepatic dysfunction in our research's findings (p 0.03).

References

Suwonkerd W, Ritthison W, Ngo CT, Tainchum K, Bangs MJ, Chareonviriyaphap T. Vector biology and malaria transmission in Southeast Asia. In Anopheles Mosquitoes-New insights into malaria vectors 2013 Jul; In tech Open.

Bygbjerg IC and Meyrowitsch DW. Global transition in health. Danish medical bulletin 2007 Feb; 54(1):44-5.

Park KS, Malik SK, Lee JH, Karim AM, Lee SH. Commentary: Malaria elimination in India and regional implications. Frontiers in Microbiology. 2018 May; 9:992.

Barber BE, Rajahram GS, Grigg MJ, William T, Anstey NM. World Malaria Report: time to acknowledge Plasmodium knowlesi malaria. Malaria journal. 2017 Dec; 16(1):1-3.

World Health Organization. World malaria report 2015. World Health Organization; 2016 Jan.

World Health Organization. World Malaria Report 2012. World Health Organization; 2012.

Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Di Marco R, Malaguarnera M. Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. The American Journal of Gastroenterology. 2006 Sep; 101(9):2060-9. doi: 10.1111/j.1572-0241.2006.00680. x.

Chan AW, Quaglia A, Haugk B, Burt A. Nonviral Infectious Liver Disease. In Atlas of Liver Pathology 2014 (pp. 105-117). Springer, New York, NY.

Gonwa TA and Wadei HM. Kidney disease in the setting of liver failure: core curriculum 2013. the American Journal of Kidney Diseases 2013 Dec; 62(6):1198-212. doi: 10.1053/j.ajkd.2013.07.017.

Anand AC and Puri P. Jaundice in malaria. Journal of Gastroenterology and Hepatology 2005 Sep; 20(9):1322-32. doi: 10.1111/j.1440-1746.2005.03884. x.

Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G. Genetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of Pakistan. Malaria Journal 2010 Apr; 9:112. doi: 10.1186/1475-2875-9-112.

Ramasamy R. Zoonotic malaria - global overview and research and policy needs. Front Public Health. 2014 Aug; 2:123. doi: 10.3389/fpubh.2014.00123.

Dondorp AM, Pongponratn E, White NJ. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta tropica 2004 Feb; 89(3):309-17. doi: 10.1016/j.actatropica.2003.10.004.

Ayoob AL, Hackner SG, Prittie J. Clinical management of canine babesiosis. Journal of Veterinary Emergency and Critical Care. 2010 Feb; 20(1):77-89. doi: 10.1111/j.1476-4431.2009.00489. x.

Ahn H, Li CS, Wang W. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatric Blood & Cancer. 2005 Aug; 45(2):184-90. doi: 10.1002/pbc.20317.

Ricci F. Social implications of malaria and their relationships with poverty. hematology and infectious diseases from Mediterranean. 2012; 4(1): e2012048. doi: 10.4084/MJHID.2012.048.

Breman JG, Alilio MS, Mills A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. The American journal of tropical medicine and Hygiene. 2004 Aug; 71(2 Suppl):1-15.

Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nature Reviews Drug Discovery. 2004 Jun; 3(6):509-20. doi: 10.1038/nrd1416.

Bhalla A, Suri V, Singh V. Malarial hepatopathy. Journal of postgraduate medicine. 2006 Oct; 52(4):315.

Anand AC and Puri P. Jaundice in malaria. Journal of Gastroenterology and Hepatology 2005 Sep; 20(9):1322-32. doi: 10.1111/j.1440-1746.2005.03884. x.

Al-Salahy M, Shnawa B, Abed G, Mandour A, Al-Ezzi A. Parasitaemia and Its Relation to Hematological Parameters and Liver Function among Patients Malaria in Abs, Hajjah, Northwest Yemen. Interdisciplinary Perspectives on Infectious Diseases. 2016; 2016:5954394. doi: 10.1155/2016/5954394.

Singh R, Kaur M, Arora D. Prospective study of hepatic involvement in Plasmodium falciparum malaria. Journal of Clinical and Diagnostic Research. 2010 Apr; 4(2):2190-7.

Fazil A, Vernekar PV, Geriani D, Pant S, Senthilkumaran S, Anwar N, et al. Clinical profile and complication of malaria hepatopathy. The Journal of Infection and Public Health. 2013 Oct; 6(5):383-8. doi: 10.1016/j.jiph.2013.04.003.

Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver International. 2008 Nov; 28(9):1190-9. doi: 10.1111/j.1478-3231.2008.01840. x.